Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (23 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2022 – 20 Aug 2026, limited by HSBC Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HSBC Value Fund | Nifty 500 |
|---|---|---|
| 28 Nov 2022 | ₹100.00 | ₹100.00 |
| 21 Mar 2023 | ₹97.50 | ₹91.30 |
| 13 Jul 2023 | ₹111.17 | ₹105.32 |
| 03 Nov 2023 | ₹122.01 | ₹107.71 |
| 25 Feb 2024 | ₹151.39 | ₹128.69 |
| 17 Jun 2024 | ₹173.28 | ₹140.74 |
| 09 Oct 2024 | ₹179.74 | ₹149.51 |
| 30 Jan 2025 | ₹163.00 | ₹134.93 |
| 23 May 2025 | ₹173.85 | ₹144.33 |
| 14 Sep 2025 | ₹178.45 | ₹146.92 |
| 05 Jan 2026 | ₹188.85 | ₹152.42 |
| 29 Apr 2026 | ₹185.10 | ₹144.90 |
| 20 Aug 2026 | ₹189.36 | ₹148.96 |
| Metric | HSBC · Regular NAV ₹115.99 Very High risk ★★★★☆ | Category median Value Fund · 23 funds |
|---|---|---|
| +4.40% | +2.35% | |
| +17.71% | +13.86% | |
| — | +13.50% | |
| — | +13.29% | |
| +18.69% | +14.30% | |
| +13.73% | — | |
| +20.80% | +16.80% | |
| — | +14.35% | |
| — | +14.21% | |
| Risk | ||
| 16.06% | 14.36% | |
| 0.70 | 0.51 | |
| 0.94 | 0.69 | |
| -19.93% | -40.31% | |
| Nifty 500 | — | |
| +4.68% | +1.91% | |
| 1.02 | 0.96 | |
| 116.2% | 101.5% | |
| 96.4% | 95.5% | |
| 1.86% | 2.28% | |
| ₹14,682Cr | ₹1,662Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 30% | 36% | |
| Mayank Chaturvedi | — | |
| 28 Nov 2022 | — | |
| 81 | — | |
| 31.7% | — | |
| 1.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.